Anna Palko-Labuz

10PUBLICATIONS
16CO-AUTHORS
Biologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
Genistein and Resveratrol: Inhibitors of Kv1.3 Channels in Cancer Cells.

|Mar 14, 2026
Co-Inhibition of Kv1.3 Channel Activity by Selected Chalcones and Statins in a Model of Cancer Cell Line Jurkat T.

Andrzej Teisseyre, Kamila Środa-Pomianek, Anna Uryga

|Jan 09, 2025
New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling.

Teresa Glomb, Kamila Środa-Pomianek, Anna Palko-Łabuz

|Sep 10, 2021
Theoretical Study of 2-(Trifluoromethyl)phenothiazine Derivatives with Two Hydroxyl Groups in the Side Chain-DFT and QTAIM Computations.

Andrzej Poła, Anna Palko-Łabuz, Kamila Środa-Pomianek

|Aug 27, 2021
Conjugation with Phospholipids as a Modification Increasing Anticancer Activity of Phenolic Acids in Metastatic Melanoma-In Vitro and In Silico Studies.

Anna Palko-Łabuz, Anna Gliszczyńska, Magdalena Skonieczna

|Aug 07, 2021
Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter.

Anna Palko-Łabuz, Maria Błaszczyk, Kamila Środa-Pomianek

Pageof 2

Frequent Collaborators

9 joint publications

Kamila Środa-Pomianek

6 joint publications

Olga Wesołowska

2 joint publications

Magdalena Skonieczna

2 joint publications

Andrzej Teisseyre